Search Browse Earnings

TENAX THERAPEUTICS, INC.

Nasdaq:TENX

Pharmaceutical Preparations·CHAPEL HILL, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Giordano Christopher Thomas

CFO

Mcgauley Thomas

Revenue

$0

FY 2025

Adj. EBITDA

-$19.5M

FY 2025

Net Income

-$17.6M

FY 2025

EPS (Diluted)

-$1.15

FY 2025

Stock Price

$14.67

+0.3%

2026-03-13

52W Range

$4.63 – $18.38

P/E Ratio

-12.8x

Market Cap

$252.3M

Cash

$94.9M

FY 2025

Total Debt

$501,000

FY 2020

Net Cash

$94.4M

FY 2020

Enterprise Value

$157.9M

Debt / EBITDA

4.8x

FY 2025

EV / EBITDA

-8.1x

Employees

—